CD44 and posterior cortical atrophy: Despite these observations supporting the candidacy of CD133+CD44+α2β1hi cells as prospective PCSCs, it still remains to be demonstrated whether CD133+CD44+α2β1hi cells isolated from primary PCa tissues are capable of tumor initiation in vivo.